Describe how ultra-long-acting basal insulins and non-steroidal MR antagonists compare with their respective drug classes and how these differences can influence their therapeutic effects in type 2 diabetes.
Illustrate strategies to start or switch to a weekly basal insulin in the management of type 2 diabetes.
Identify practical considerations of using non-steroidal mineralocorticoid receptor (nsMR) antagonists in the setting of diabetic nephropathy in type 2 diabetes.
Determine when beta-blockers are no longer indicated post myocardial infarction and identify patients who are ideal candidates for discontinuing beta-blocker therapy.
Define when combinations of antiplatelet and anticoagulation medications are indicated in cardiovascular disease and identify patients who are ideal candidates for anticoagulation monotherapy.
Discuss evidence highlights from the latest data syntheses about the risks and benefits of testosterone replacement therapy.
Compare and contrast the new and tried, tested, and true approaches for the treatment of erectile dysfunction.